MiMedx will host a live broadcast of its Guidance conference call on Wednesday, December 13, 2017, at 10:30 a.m. eastern time.
|
[12-December-2017] |
MARIETTA, Ga., Dec. 12, 2017 /PRNewswire/ -- MiMedx (NASDAQ: MDXG), the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today that its 2018 Guidance will be released before the opening of the market on Wednesday, December 13, 2017. MiMedx will host a live broadcast of its Guidance conference call on Wednesday, December 13, 2017, at 10:30 a.m. eastern time. A listen-only simulcast of the MiMedx conference call will be available online at the Company’s website, www.mimedx.com. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. The replay can also be found on the Company’s website at www.mimedx.com. About MiMedx View original content:http://www.prnewswire.com/news-releases/mimedx-announces-release-of-2018-guidance-and-shareholder-conference-call-300570259.html SOURCE MiMedx Group, Inc. | ||
Company Codes: NASDAQ-SMALL:MDXG |